Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

PET-CT accurately predicts the pre-operative characteristics of colorectal hepatic metastases.

Jones C, Badger SA, McKie LD, Diamond T, Taylor MA, Lynch TB.

Eur J Surg Oncol. 2012 Dec;38(12):1184-8. doi: 10.1016/j.ejso.2012.07.001. Epub 2012 Aug 9.

PMID:
22883963
2.

The role of 18FDG PET/CT in the management of colorectal liver metastases.

Engledow AH, Skipworth JR, Pakzad F, Imber C, Ell PJ, Groves AM.

HPB (Oxford). 2012 Jan;14(1):20-5. doi: 10.1111/j.1477-2574.2011.00378.x. Epub 2011 Nov 14.

4.

Role of PET/CT in the detection of liver metastases from colorectal cancer.

Orlacchio A, Schillaci O, Fusco N, Broccoli P, Maurici M, Yamgoue M, Danieli R, D'Urso S, Simonetti G.

Radiol Med. 2009 Jun;114(4):571-85. doi: 10.1007/s11547-009-0393-7. Epub 2009 May 14. English, Italian.

PMID:
19444590
5.

PET-CT as a predictor of outcome in resectable colorectal liver metastases.

Jones C, Badger SA, Stevenson M, Diamond T, McKie LD, Taylor MA, Wilson RH, Lynch TB.

Eur J Gastroenterol Hepatol. 2014 Apr;26(4):466-72. doi: 10.1097/MEG.0000000000000036.

PMID:
24445726
6.

FDG-PET for the pre-operative evaluation of colorectal liver metastases.

Arulampalam TH, Francis DL, Visvikis D, Taylor I, Ell PJ.

Eur J Surg Oncol. 2004 Apr;30(3):286-91.

PMID:
15028310
7.

Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer.

Strasberg SM, Dehdashti F.

J Surg Oncol. 2010 Dec 15;102(8):955-9. doi: 10.1002/jso.21729. Review.

PMID:
21165998
8.

The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.

Brush J, Boyd K, Chappell F, Crawford F, Dozier M, Fenwick E, Glanville J, McIntosh H, Renehan A, Weller D, Dunlop M.

Health Technol Assess. 2011 Sep;15(35):1-192, iii-iv. doi: 10.3310/hta15350. Review.

9.

Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT.

Wildi SM, Gubler C, Hany T, Petrowsky H, Clavien PA, Jochum W, Gerlach T, Fried M, Mullhaupt B.

J Clin Ultrasound. 2008 Jan;36(1):20-6.

PMID:
17937421
10.

Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT?

Ramos E, Valls C, Martinez L, Lladó L, Torras J, Ruiz S, Gamez C, Serrano T, Fabregat J, Rafecas A.

Ann Surg Oncol. 2011 Sep;18(9):2654-61. doi: 10.1245/s10434-011-1670-y. Epub 2011 Mar 24.

PMID:
21431987
11.

FDG-PET improves management of patients with colorectal liver metastases allocated for local treatment: a consecutive prospective study.

Sørensen M, Mortensen FV, Høyer M, Vilstrup H, Keiding S; Liver Tumour Board at Aarhus University Hospital..

Scand J Surg. 2007;96(3):209-13.

PMID:
17966746
12.

Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.

Briggs RH, Chowdhury FU, Lodge JP, Scarsbrook AF.

Clin Radiol. 2011 Dec;66(12):1167-74. doi: 10.1016/j.crad.2011.07.046. Epub 2011 Aug 24.

PMID:
21867996
13.

Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery.

Wiering B, Ruers TJ, Krabbe PF, Dekker HM, Oyen WJ.

Ann Surg Oncol. 2007 Feb;14(2):818-26. Epub 2006 Nov 29.

PMID:
17136470
14.

Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.

Abbadi RA, Sadat U, Jah A, Praseedom RK, Jamieson NV, Cheow HK, Whitley S, Ford HE, Wilson CB, Harper SJ, Huguet EL.

J Surg Oncol. 2014 Sep;110(3):313-9. doi: 10.1002/jso.23623. Epub 2014 Apr 16.

PMID:
24737685
15.

Positron emission tomography with F-18 fluorodeoxyglucose in evaluating colorectal hepatic metastasis down-staged by chemotherapy.

Takahashi S, Kuroki Y, Nasu K, Nawano S, Konishi M, Nakagohri T, Gotohda N, Saito N, Kinoshita T.

Anticancer Res. 2006 Nov-Dec;26(6C):4705-11.

16.

18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases.

Riedl CC, Akhurst T, Larson S, Stanziale SF, Tuorto S, Bhargava A, Hricak H, Klimstra D, Fong Y.

J Nucl Med. 2007 May;48(5):771-5.

17.

Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study.

Ruers TJ, Wiering B, van der Sijp JR, Roumen RM, de Jong KP, Comans EF, Pruim J, Dekker HM, Krabbe PF, Oyen WJ.

J Nucl Med. 2009 Jul;50(7):1036-41. doi: 10.2967/jnumed.109.063040. Epub 2009 Jun 12.

18.

PET/CT: will it change the way that we use CT in cancer imaging?

Hicks RJ, Ware RE, Lau EW.

Cancer Imaging. 2006 Oct 31;6:S52-62.

19.

Neither preoperative computed tomography nor intra-operative examination can predict metastatic lymph node in the hepatic pedicle in patients with colorectal liver metastasis.

Rau C, Blanc B, Ronot M, Dokmak S, Aussilhou B, Faivre S, Vilgrain V, Paradis V, Belghiti J.

Ann Surg Oncol. 2012 Jan;19(1):163-8. doi: 10.1245/s10434-011-1994-7. Epub 2011 Aug 12.

PMID:
21837526
20.

Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases.

Fong Y, Saldinger PF, Akhurst T, Macapinlac H, Yeung H, Finn RD, Cohen A, Kemeny N, Blumgart LH, Larson SM.

Am J Surg. 1999 Oct;178(4):282-7.

PMID:
10587184

Supplemental Content

Support Center